NCCN Guidelines Updates: Management of Prostate Cancer

James L. Mohler, Emmanuel S. Antonarakis

Research output: Contribution to journalLetterpeer-review

Abstract

Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.

Original languageEnglish (US)
Pages (from-to)583-586
Number of pages4
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume17
Issue number55
DOIs
StatePublished - May 1 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'NCCN Guidelines Updates: Management of Prostate Cancer'. Together they form a unique fingerprint.

Cite this